Updated
Reviewed
Aug. 01, 2019
Appendix B: Panel Roster and Financial Disclosures
Syphilis
| Member | Financial Disclosure | ||
|---|---|---|---|
| Company | Relationship | ||
| Bolan, Gail | Centers for Disease Control and Prevention | None | N/A |
| Ghanem, Khalil | Johns Hopkins University | None | N/A |
| Hollier, Lisa | Baylor College of Medicine | None | N/A |
| Hook, Edward W. | University of Alabama at Birmingham | National Institutes of Health | Research Support |
| Sena, Arlene | University of North Carolina | Gilead Sciences | Research Support |
| GlaxoSmithKline | Research Support | ||
| Hologic, Inc | Speaking Compensation, Advisory Board | ||
| Lupin Pharmaceuticals, Inc | Research Support | ||
| UpToDate | Royalties | ||
| Stoner, Brad | Washington University School of Medicine | None | N/A |
| Workowski, Kim* | Emory University | Acuris | Research Support |
| Gilead Sciences | Advisory Board, Research Support | ||
| GlaxoSmithKline | Advisory Board, Research Support | ||
| Janssen Pharmaceuticals | Advisory Board | ||
* Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019. |
|||
Download Guidelines
- Section OnlyPDF (507.01 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)